Ronald Blue Trust, Inc. Fulgent Genetics, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 97 shares of FLGT stock, worth $1,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97
Previous 276
64.86%
Holding current value
$1,725
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FLGT
# of Institutions
198Shares Held
16MCall Options Held
1.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$69.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$25.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$22.6 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$19.7 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$14.1 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $538M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...